| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.086 | 0.07 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.28 | 0.07 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.08 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.09 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.09 |